Apoptosis, A Double-Edge Sword!

by Xavier Rossello, MD, Derek M. Yellon, DSc
Published 2017-08-01

Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential

by Kaloyan Takov, Derek M. Yellon, Sean M. Davidson
Published 2019-12-01

Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes

by Kaloyan Takov, Derek M. Yellon, Sean M. Davidson
Published 2017-12-01

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?

by Maryna V Basalay, Sean M Davidson, Derek M Yellon
Published 2020-01-01

A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies.

by Daniel I Bromage, Stasa Taferner, Mahesh Pillai, Derek M Yellon, Sean M Davidson
Published 2017-01-01

Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow∗

by Derek M. Yellon, PhD, DSc, John Malcolm Walker, MD, Sapna Arjun, PhD
Published 2019-12-01

The Diabetic Heart: Too Sweet for Its Own Good?

by Hannah J. Whittington, Girish G. Babu, Mihaela M. Mocanu, Derek M. Yellon, Derek J. Hausenloy
Published 2012-01-01

Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning

by Sean M. Davidson, Jaime A. Riquelme, Ying Zheng, Jose M. Vicencio, Sergio Lavandero, Derek M. Yellon
Published 2018-10-01

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

by Daniel I. Bromage, Tom R. Godec, Mar Pujades-Rodriguez, Arturo Gonzalez-Izquierdo, S. Denaxas, Harry Hemingway, Derek M. Yellon
Published 2019-12-01

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart

by Ven G. Lim, MBChB, Robert M. Bell, PhD, Sapna Arjun, PhD, Maria Kolatsi-Joannou, PhD, David A. Long, PhD, Derek M. Yellon, PhD, DSc
Published 2019-02-01

Effect of Remote Ischaemic preconditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised co...

by Derek J Hausenloy, Luciano Candilio, Richard Evans, Cono Ariti, David P Jenkins, Shyamsunder Kolvekar, Rosemary Knight, Gudrun Kunst, Christopher Laing, Jennifer M Nicholas, John Pepper, Steven Robertson, Maria Xenou, Timothy Clayton, Derek M Yellon
Published 2016-06-01

Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury

by Hilary K. Siddall, Derek M. Yellon, Sang-Bing Ong, Uma A. Mukherjee, Niall Burke, Andrew R. Hall, Plamena R. Angelova, Marthe H. R. Ludtmann, Emma Deas, Sean M. Davidson, Mihaela M. Mocanu, Derek J. Hausenloy
Published 2013-01-01

Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury.

by Hilary K. Siddall, Derek M. Yellon, Sang-Bing Ong, Uma A. Mukherjee, Niall Burke, Andrew R. Hall, Plamena R. Angelova, Marthe H. R. Ludtmann, Emma Deas, Sean M. Davidson, Mihaela M. Mocanu, Derek J. Hausenloy
Published 2013-01-01

Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury.

by Hilary K Siddall, Derek M Yellon, Sang-Bing Ong, Uma A Mukherjee, Niall Burke, Andrew R Hall, Plamena R Angelova, Marthe H R Ludtmann, Emma Deas, Sean M Davidson, Mihaela M Mocanu, Derek J Hausenloy
Published 2013-01-01

Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance

by Rachel K. Dongworth, Adrienne E. Campbell-Washburn, Hector A. Cabrera-Fuentes, Heerajnarain Bulluck, Thomas Roberts, Anthony N. Price, Sauri Hernández-Reséndiz, Roger J. Ordidge, David L. Thomas, Derek M. Yellon, Mark F. Lythgoe, Derek J. Hausenloy
Published 2017-05-01